You are here: Industry Insights > Blackstone

News List

Healthcare industry reports 106 deals worth $49.7 billion in June 2021 expresspharma
July 08, 2021
In June 2021, the healthcare industry reported 106 deals worth $49.7 billion as compared to the last 12-month average (June 2020 to May 2021) of 104 deals worth $23.4 billion.
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company americanpharmaceuticalreview
June 23, 2021
Blackstone Life Sciences has committed $250 million towards the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell therapy company, along with Intellia Therapeutics, Inc. and Cellex Cell Professionals GmbH.
Takeda to offload Japan consumer health unit to Blackstone for $2.3 billion fiercepharma
August 26, 2020
After months of rumors, Takeda has finally unveiled a deal to sell its Japanese consumer health business to Blackstone Group.
Blackstone to acquire anti-rheumatism drugs maker Ayumi Pharmaceutical pharmaceutical-technology
March 19, 2019
Blackstone’s private equity funds have signed a definitive agreement to acquire Japan-based anti-rheumatism drugs manufacturer Ayumi Pharmaceutical from Unison Capital and M3.
Blackstone, Novartis found cardiovascular startup with $250M fiercebiotech
February 28, 2019
Blackstone Life Sciences has committed $250 million to create a cardiovascular startup with Novartis. The biotech, Anthos Therapeutics....